GlassScriptPhysician profile
Melinda B Hart
NPI 1174528020
$3,265.30
in general payments reported to CMS, 2019-2025
40 companies · $502 in 2025
The $502 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $505 · 2020: $466 · 2021: $616 · 2022: $494 · 2023: $305 · 2024: $378 · 2025: $502.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,183.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $615.93 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Pfizer INC. | $513.93 | 2019-2024 | |
| Abbvie INC. | $366.11 | 2021-2025 | |
| Astellas Pharma US INC | $258.09 | 2019-2024 | Veozah |
| Corcept Therapeutics | $118.88 | 2021-2025 | Korlym |
| Janssen Pharmaceuticals, INC | $116.09 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $104.45 | 2019-2025 | |
| Glaxosmithkline, LLC. | $96.47 | 2019-2023 | Trelegy Ellipta, Shingrix, Arexvy |
| Bayer Healthcare Pharmaceuticals INC. | $90.03 | 2023-2025 | |
| Xeris Pharmaceuticals, INC. | $88.64 | 2022-2025 | Recorlev |
| Amarin Pharma, INC. | $71.22 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $66.29 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $62.32 | 2019-2022 | |
| Amgen INC. | $51.64 | 2023-2024 | Repatha, Otezla |
| Astrazeneca Pharmaceuticals LP | $46.52 | 2023-2024 | Airsupra |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $44.94 | 2021-2025 | Nexletol |
| Novartis Pharmaceuticals Corporation | $41.22 | 2019-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $35.52 | 2022-2025 | Trintellix |
| Csl Behring | $32.21 | 2019-2020 | |
| Exact Sciences Corporation | $31.85 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Ironwood Pharmaceuticals, INC | $30.83 | 2019-2020 | |
| Allergan, INC. | $29.43 | 2020 | |
| Horizon Therapeutics Plc | $29.31 | 2022 | |
| Currax Pharmaceuticals LLC | $29.01 | 2023 | Contrave, Nexlizet, Nexletol |
| Medtronic, INC. | $27.68 | 2021-2024 | Minimed 780g |
| Merck Sharp & Dohme LLC | $27.45 | 2019 | |
| Medicomp INC | $23.23 | 2024 | Telepatch Cardiac Monitor |
| Biogen, INC. | $21.96 | 2025 | Leqembi |
| Inspire Medical Systems, INC. | $21.16 | 2025 | Inspire |
| Sanofi Pasteur INC. | $19.42 | 2025 | |
| Ultragenyx Pharmaceutical INC. | $18.47 | 2021 | |
| Halozyme INC | $18.22 | 2023 | |
| Insmed, INC. | $17.27 | 2025 | Arikayce |
| Sumitomo Pharma America, INC. | $17.07 | 2023 | Gemtesa |
| Phathom Pharmaceuticals, INC. | $16.17 | 2024 | Voquezna |
| Emmaus Medical, INC. | $15.26 | 2021 | |
| Celgene Corporation | $14.34 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.79 | 2021 | |
| Radius Health, INC. | $12.45 | 2021 | |
| Tandem Diabetes Care, INC. | $11.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melinda Hart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.